Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Reiterates a 'Buy' Rating on Motorola (MOT); Positive on Split
-
Canaccord Adams Maintains a 'Buy' on Rovi Corporation (ROVI); Strong Q4 Beat
-
Canaccord Adams Maintains a 'Hold' on Vale (VALE); Lowers PT & Estimates
-
Canaccord Adams Upgrades EnCana (ECA) to Buy; Raises PT & Estimates
-
Labopharm (DDSS) Prices 11.76M Common Offering at $1.70/Unit
-
Canaccord Adams Reiterates a 'Buy' on Insulet Corp (PODD); Raises PT After Q4 Results
-
Canaccord Adams Initiates Coverage on Swift Energy (SFY) with a Buy; Legacy Assets Providing a Launch Pad
-
Canaccord Adams Initiates Coverage on Gastar Exploration (GST) with a Buy; Digging Deep for Returns
-
Canaccord Adams Reiterates a 'Buy' on HeartWare International (HTWR); Adjusts Price Target & Estimates
-
Canaccord Adams Raises Price Target On Labopharm (DDSS) After Oleptro Approval, Partnership Is Next
-
Canaccord Adams Riterates a 'Buy' on Concur Technologies (CNQR); Raises PT
-
Canaccord Adams Maintains a 'Buy' on Motorola (MOT); Reduces Estimates & PT
-
Wall Street's Thoughts On Microsoft (MSFT) After Strong Q4 Driven By Windows 7
-
Wall Street's Thoughts On Apple's (AAPL) iPad
-
Canaccord Adams Maintains a 'Buy' on New Gold Inc. (NGD); Slight Positive on Sale of Amapari Mine
-
Canaccord Adams Reiterates a 'Buy' on Green Mountain Coffee (GMCR); Raises PT & Estimates
-
Canaccord Adams Initiates Coverage on Medicis Pharmaceutical (MRX) with a Buy
-
Canaccord Adams Reiterates a 'Buy' on Intersil (ISIL); Raises PT & Estimates
-
Canaccord Adams Reiterates a 'Buy' on Baker Hughes (BHI); Raises PT
-
Canaccord Adams Maintains a 'Buy' on Yahoo! (YHOO); Raises PT
-
Canaccord Adams Reiterates a 'Buy' on Stryker (SYK); Raises PT
-
Daily State of the Markets 1/27: Guess They're Serious
-
Canaccord Adams Upgrades QLogic (QLGC) to Buy
-
Canaccord Adams Initiates Coverage on Nexxus Lighting (NEXS) with a Buy
-
Analyst Thoughts On Apple (AAPL) After Strong Q1 Results
-
Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN)
-
Unusual 11 Mid-Day Movers 1/25: SMTX, NBS, KFS, SILC, PVTB Higher; PARD, ZAGG, DEAR, BBX Lower
-
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
-
Notable Analyst Rating Changes 01/25: GD, SOLF, DRYS, EGLE, SAP Upgraded; PRSP, PARD, IGT, LPX, TSS Downgraded
-
Canaccord Adams Downgrades Poniard Pharmaceuticals (PARD) to Sell; Slight Picoplatin Underperformance
-
Analyst Thoughts On Google (GOOG) After Solid Q4 Results and Subsequent Sell-Off
-
Canaccord Adams Adds ArthroCare (ARTC) to 'Best Ideas' List for 2010
-
Canaccord Adams Reiterates a 'Hold' on AMD (AMD); Raises PT & Estimates
-
Notable Analyst Rating Changes 01/22: JPM, CNX, PERY, SPRD Upgraded; FCX, WABC, ZLC, JOYG Downgraded
-
Canaccord Adams Initiates Coverage on NCI Building Systems (NCS) with a Buy
-
Apple (AAPL) Q1 Earnings Preview
-
Canaccord Getting Bullish on Oil Service Stocks Heading Into February
-
Notable Mergers and Acquisitions of the Day 1/21: ORCL/JAVA, MATK, FIT, A/VARI
-
Canaccord Adams Reiterates a 'Buy' on Xilinx (XLNX); New Products Help Drive Upside - Raises Estimates
-
Daily State of the Markets 1/21: Rewind to the Unwind?
-
Martek Biosciences (MATK) Enters Agreement to Buy Amerifit Brands for $200M in Cash; Raises Q1 Guidance
-
AMAG Pharma (AMAG) Prices 3.6M Common Offering at $48.25/Share
-
InterMune (ITMN) Prices 7M Common Offering at $14.10/Share
-
Analyst Thoughts On IBM's (IBM) Strong Q4 Results
-
Notable Analyst Rating Changes 01/20: KELYA, CBS, SHPGY, SWIR, IBM Upgraded; TSCO, BIG, AAP, VRS, CPO Downgraded
-
Daily State of the Markets 1/20: Gridlock At Last?
-
Canaccord Adams Upgrades IBM Corp (IBM) to Buy; Raises Estimates & PT on Strong Management Execution
-
IBM (IBM) Reports Strong Q4 Results As Sales Growth Resumes
-
Apple (AAPL) Shares Up 4% as Analysts Weighing In Ahead of Jan. 27 Event
-
Research In Motion's (RIMM) New Browser Will Be a "Game Changer" - Analyst
